FDA Gluten Labeling Changes 2026 Explained
In January 2026, the U.S. Food and Drug Administration (FDA) announced new steps to review how gluten is disclosed on food labels, including issuing a Request for Information (RFI) to gather public input on gluten-containing ingredients and cross-contact risks.
While no new rule has taken effect yet, this action signals a potential shift in how gluten is labeled on packaged foods—and how restaurants may be expected to communicate gluten risks to consumers going forward.
For restaurants and consumers affected by gluten-related health conditions, the FDA's review highlights growing concern that current labeling practices may not provide enough clarity to prevent gluten exposure.
Why FDA Gluten Labeling Changes Matter
Gaps in Current Gluten Labeling Rules
Under existing U.S. food labeling laws:
- Only wheat is classified as a major allergen
- Other gluten-containing grains—barley and rye—are not required to be clearly disclosed
- Gluten cross-contact risks are inconsistently communicated
This creates challenges for individuals with celiac disease or gluten sensitivity, who must rely on ingredient knowledge rather than standardized disclosure.
The FDA's 2026 review is intended to evaluate whether these gaps pose a public health risk and whether clearer gluten ingredient disclosure is needed.
What the FDA Is Evaluating
The FDA is seeking information on:
- Adverse health effects linked to gluten exposure
- Consumer understanding of current gluten labels
- The role of barley, rye, and oats with cross-contact risk
- Whether current regulations adequately protect people with celiac disease
This mirrors broader food labeling trends focused on transparency, consistency, and consumer safety.
What This Means for Restaurants
Although the FDA action currently applies to packaged foods, restaurants should not ignore it. Historically, federal reviews like this often influence:
- State-level menu disclosure laws
- Health department enforcement priorities
- Expectations for allergen and sensitivity transparency
- Consumer trust and liability exposure
Key Areas Restaurants Should Review Now
Restaurants should begin assessing:
- Menu language related to gluten-containing ingredients
- Supplier documentation for barley, rye, and oat-based ingredients
- Gluten cross-contact controls in shared kitchens
- Staff training on gluten sensitivity and celiac disease
- Use of "gluten-free" claims without verified safeguards
Important: Proactive preparation reduces legal risk and improves customer confidence.
Gluten Cross-Contact: A Growing Focus
Cross-contact is one of the most common causes of unintended gluten exposure and a major concern raised in the FDA's review.
Common restaurant risk points include:
- Shared fryers and grills
- Prep surfaces used for breaded items
- Bulk ingredient storage
- Oats processed alongside wheat or barley
Remember: Restaurants offering gluten-free options without managing cross-contact may face increased scrutiny as regulatory expectations evolve.
Potential Regulatory Outcomes to Watch
While no final rule has been issued, potential outcomes of the FDA's review include:
- Clearer definitions of gluten-containing ingredients
- Expanded disclosure expectations beyond wheat
- Updated guidance for gluten-free claims
- Increased enforcement against misleading gluten representations
Restaurants that align early with best practices will be better positioned if requirements change.
What Restaurants Should Do Now
Recommended Preparation Steps
Restaurant operators should:
Conduct a Gluten Ingredient Audit
Review all menu items to identify gluten-containing ingredients, including hidden sources like barley malt and rye flour.
Request Updated Supplier Documentation
Obtain current ingredient and allergen specifications from all suppliers, especially for products containing oats, barley, or rye.
Document Cross-Contact Prevention
Create written procedures for preventing gluten cross-contact in food preparation areas and shared equipment.
Train Staff on Gluten Risks
Ensure all team members can accurately communicate gluten risks and understand the severity of celiac disease.
Verify Gluten-Free Claims
Avoid absolute gluten-free claims unless proper controls are verified and documented.
These steps support celiac disease compliance and long-term regulatory readiness.
Frequently Asked Questions
What are the FDA gluten labeling changes in 2026?
In 2026, the FDA issued a Request for Information to review whether current gluten labeling practices adequately protect consumers and whether clearer disclosure of gluten-containing ingredients is needed.
Are restaurants required to change menus now?
No. The FDA has not implemented new mandatory rules yet, but restaurants should prepare for possible future guidance or state-level requirements.
Why isn't gluten labeled like other allergens?
Only wheat is classified as a major allergen under U.S. law. Other gluten-containing grains like barley and rye are not required to be disclosed in the same way.
How can restaurants reduce gluten-related liability?
By improving ingredient transparency, managing cross-contact risks, training staff, and avoiding misleading gluten-free claims without safeguards.
Why This Matters for Consumers
For consumers with celiac disease or gluten sensitivity:
- Clearer labeling reduces accidental exposure
- Transparency builds trust in restaurants
- Consistent disclosure supports informed dining decisions
The FDA's review reflects increasing recognition that gluten safety requires more than voluntary disclosure.